Media coverage
1Media coverage
Title Cyclacel Pharmaceuticals, Inc. (CYCC)'s Second-Generation CDK2/9 Inhibitor, CYC065, Demonstrates Therapeutic Potential And Synergy With Other Anti-Cancer Compounds 4/20/2015 Media name/outlet ClinicSpace Country Canada Date 4/20/15 Persons Jing Wang